Theranexus SA (ALTHX) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.106x

Based on the latest financial reports, Theranexus SA (ALTHX) has a cash flow conversion efficiency ratio of -0.106x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€199.30K ≈ $233.00K USD) by net assets (€-1.89 Million ≈ $-2.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Theranexus SA - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Theranexus SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Theranexus SA carry for a breakdown of total debt and financial obligations.

Theranexus SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theranexus SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
XTPL SA WAR:XTP	-0.187x
Ekarat Engineering Public Company Limited BK:AKR	0.103x
ORIENTBIO Inc. KO:002630	0.001x
Royalty Management Holding Corporation NASDAQ:RMCO	0.002x
AS Pro Kapital Grupp F:17E	-0.031x
HUBLine Bhd KLSE:7013	0.134x
Acuvi AB ST:ACUVI	0.000x
Metallic Minerals Corp V:MMG	-0.327x

Annual Cash Flow Conversion Efficiency for Theranexus SA (2015–2024)

The table below shows the annual cash flow conversion efficiency of Theranexus SA from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see ALTHX company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-1.66 Million ≈ $-1.94 Million	€-3.37 Million ≈ $-3.94 Million	2.033x	+171.04%
2023-12-31	€2.22 Million ≈ $2.60 Million	€-6.36 Million ≈ $-7.43 Million	-2.862x	-205.08%
2022-12-31	€5.73 Million ≈ $6.70 Million	€-5.37 Million ≈ $-6.28 Million	-0.938x	-52.84%
2021-12-31	€10.18 Million ≈ $11.90 Million	€-6.25 Million ≈ $-7.31 Million	-0.614x	-11.20%
2020-12-31	€10.28 Million ≈ $12.02 Million	€-5.68 Million ≈ $-6.64 Million	-0.552x	-8.61%
2019-12-31	€9.98 Million ≈ $11.66 Million	€-5.07 Million ≈ $-5.93 Million	-0.508x	-21.77%
2018-12-31	€13.41 Million ≈ $15.68 Million	€-5.60 Million ≈ $-6.54 Million	-0.417x	-312.77%
2017-12-31	€18.71 Million ≈ $21.87 Million	€-1.89 Million ≈ $-2.21 Million	-0.101x	+99.38%
2016-12-31	€89.85K ≈ $105.05K	€-1.47 Million ≈ $-1.72 Million	-16.406x	-3069.12%
2015-12-31	€1.68 Million ≈ $1.96 Million	€-867.96K ≈ $-1.01 Million	-0.518x	--

About Theranexus SA

PA:ALTHX France Biotechnology

Market Cap

$54.40 Million

€46.53 Million EUR

Market Cap Rank

#22431 Global

#355 in France

Share Price

€3.38

Change (1 day)

-1.74%

52-Week Range

€0.45 - €4.37

All Time High

€22.70